This inventor holds 2 USPTO granted patents and 12 published patent applications. Top assignees: Beone Medicines | Gmbh, Beone Medicines I Gmbh. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Bailin Lei - Innovator in Bifunctional Compounds
Introduction
Bailin Lei is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biochemistry, particularly in the development of innovative compounds for targeted protein degradation.
Latest Patents
Bailin Lei holds a patent for "Bifunctional compounds for degradation of EGFR and related methods of use." This patent discloses bifunctional compounds formed by conjugating EGFR inhibitor moieties with E3 ligase ligand moieties. These compounds function to recruit targeted proteins to E3 ubiquitin ligase for the degradation of mutant EGFR kinase, along with methods of preparation and uses thereof. He has 1 patent to his name.
Career Highlights
Bailin Lei is currently associated with Beone Medicines GmbH, where he continues to work on groundbreaking research and development in the pharmaceutical sector. His expertise in biochemistry and innovative thinking has positioned him as a valuable asset in his field.
Collaborations
Bailin collaborates with notable colleagues, including Huaqing Liu and Songzhe Han, who contribute to his research endeavors and help advance the development of new therapeutic solutions.
Conclusion
Bailin Lei's work in the field of bifunctional compounds showcases his innovative spirit and dedication to advancing medical science. His contributions are paving the way for new treatments and therapies in the fight against diseases related to mutant EGFR kinase.